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In the present work, the preparation, characterization and therapeutic potential of baicalin-loaded 
nanohydrogels are reported. The nanohydrogels were prepared by sonicating (S nanohydrogel) or 
autoclaving (A nanohydrogel) a dispersion of cholesterol-derivatized gellan in phosphate buffer. 
The nanohydrogel obtained by autoclave treatment showed the most promising results: smaller 
particles (~362 nm vs. ~530 nm), higher homogeneity (polydispersity index = ~0.24 vs. ~0.47), and 
lower viscosity than those obtained by sonication. In vitro studies demonstrated the ability of the 
nanohydrogels to favour the deposition of baicalin in the epidermis. A high biocompatibility was 
found for baicalin-loaded nanohydrogels, along with a great ability to counteract the toxic effect 
induced by hydrogen peroxide in cells, as the nanohydrogels re-established the normal conditions 
(~100% viability). Further, the potential of baicalin-loaded nanohydrogels in skin wound healing 
was demonstrated in vivo in mice by complete skin restoration and inhibition of specific 
inflammatory markers (i.e., myeloperoxidase, tumor necrosis factor-, and oedema). 
 






Gellan is a linear anionic polysaccharide showing a repeating unit based on a tetrasaccharide of β-
1,3-d-glucose, β-1,4-d-glucuronic acid, and α-1,4-l-rhamnose [1]. It is water soluble and forms 
transparent hydrogels, even at low concentrations [2], by interaction with mono and divalent 
cations. The mechanism of gelation involves formation of double helical junction zones by the 
polymer strands, followed by aggregation of the hydrophobic double helical segments to form a 
three-dimensional network by complexation with cations and hydrogen bonding with water [3]. 
Gellan, even if useful in the native state, can benefit from a chemical conjugation with lipophilic 
molecules, e.g. cholesterol. In this case, its solubility in aqueous environment is altered, leading to 
an insoluble material. This new property can be exploited in order to shape a new drug delivery 
vehicle with soft hydrogel characteristics [4]. More precisely, the chemical derivatization of the 
carboxyl groups of gellan with a hydrophobic moiety is responsible for a self-assembling process 
resulting in the formation of nanosized particles capable of incorporating and delivering lipophilic 
molecules. Such nanohydrogel system was previously developed and tested for systemic 
administration of different drugs [4–6]. 
Baicalin (7-glucuronic acid 5, 6-dihydroxyflavone) is a flavone isolated from the roots of 
Scutellaria baicalensis, a medicinal plant widely used in East Asian countries for the treatment of 
various inflammatory diseases. The anti-inflammatory activity of baicalin has been attributed to its 
antioxidant properties and ability to inhibit nitric oxide and tumor necrosis factor-α (TNF-α) levels 
[7]. Recent studies reported the therapeutic properties of baicalin and its low bioavailability, 
especially when applied topically [8,9]. Hence, the incorporation of the polyphenol in nanocarrier 
systems can represent an effective approach to improve its bioavailability and modulate its release 
over time [10,11]. 




In this work, the derivatization of gellan with cholesterol is presented, along with the preparation of 
nanohydrogels by using two techniques: sonication and autoclaving. The obtained nanohydrogels 
were characterized by size, zeta potential, rheological behaviour, and capability of delivering 
baicalin to the skin. Moreover, the biocompatibility and antioxidant activity of the baicalin loaded 
nanohydrogels were assessed in vitro using fibroblasts, and their potential in protecting the skin 
from chemically-induced injury was investigated in vivo in an animal model of chronic wound. 
2. EXPERIMENTAL SECTION 
2.1. Materials 
Gellan tetrabutylammonium salt was kindly provided by Giusto Faravelli (Milan, Italy). Baicalin, 
cholesterol, 4-bromobutyric acid, N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride 
(EDC·HCl), 12-O-tetradecanoylphorbol 13-acetate (TPA) and other reagents of analytical grade 
were purchased from Sigma-Aldrich (Milan, Italy). Phosphate buffer solution (PBS, pH 7) was 
purchased from Carlo Erba (Cornaredo, Milan, Italy). Cell medium, fetal bovine serum, 
penicillin/streptomycin, and fungizone were purchased from Life Technologies Europe (Monza, 
Italy). Betnovate
®
 cream (betamethasone 0.1%; GlaxoSmithKline, Verona, Italy) was purchased in 
a local drugstore. 
2.2. Gellan-cholesterol synthesis and nanohydrogel preparation 
The synthesis of gellan-cholesterol derivative was carried out according to a previously developed 
procedure [5]. Briefly, cholesterol (500 mg, 1.3 mmol) and 4-(dimethylamino)pyridine (79 mg, 0.65 
mmol) were solubilized in dichloromethane (7 ml). EDC-HCl (744 mg, 3.9 mmol) and 4-
bromobutyric acid (648 mg, 3.9 mmol) were solubilized in dichloromethane (7 ml). The two 
solutions were mixed, kept at room temperature for 6 h, washed with NaOH (0.05 M), HCl (0.05 
M) and distilled water (three times), and dried over anhydrous Na2SO4. The solvent was removed 
by rotary evaporation, and the crude was purified on silica column with ethylacetate:cyclohexane 




(1 g) was dissolved in N-methyl-2-pyrrolidone (135 ml), and Br-butyric-cholesterol (100 mg) 
dissolved in N-methyl-2-pyrrolidone was added (39 ml). The reaction was kept under magnetic 
stirring for 40 h, at 38 °C. Thereafter, an exhaustive dialysis against distilled water (Visking tubing, 
12–14 KDa cut-off) was carried out, and the gellan-cholesterol was recovered by freeze-drying. The 
derivatization degree of gellan-cholesterol was 9% (mol of cholesterol vs. mol of carboxylic groups 
of the polymer) [5]. To produce the nanohydrogels, gellan-cholesterol (20 mg) was dispersed in 
PBS (10 ml) and the suspension was: (a) sonicated for 200 cycles, 5 s on / 2 s off, at 13 microns of 
probe amplitude, with a high intensity ultrasonic disintegrator (Soniprep 150, MSE Crowley, UK) 
to obtain the sonicated (S) nanohydrogel; (b) autoclaved at 121 °C for 30 min to produce the 
autoclaved (A) nanohydrogel. Baicalin was added (10 mg/ml) to the pre-formed nanohydrogels and 
moderately sonicated (25 cycles, 2 s on / 2 s off), so that the polyphenol is homogeneously 
embedded within the nanohydrogel network. 
2.3. Nanohydrogel characterization 
Particle average diameter and polydispersity index (PI; a dimensionless measure of the broadness of 
the size distribution) were determined by Photon Correlation Spectroscopy using a Zetasizer nano-
ZS (Malvern Instruments, Worcestershire, UK), which analyzes the fluctuations in intensity of the 
light backscattered by the particles in dispersion. Zeta potential was estimated using the Zetasizer 
nano-ZS by means of the M3-PALS (Mixed Mode Measurement-Phase Analysis Light Scattering) 
technique, which measures particle electrophoretic mobility [13]. 
Entrapment efficiency (EE%) was expressed as the percentage of baicalin recovered after dialysis 
vs. the amount initially used. Baicalin nanohydrogels (2 ml) were dialysed in Spectra/Por tubing 
(12–14 KDa cut-off) against PBS (2 l) for 2 h, to remove free baicalin. The nanoparticles were 
treated with methanol (1:1000) and the baicalin content was determined by high performance liquid 
chromatography (HPLC) using a Perkin Elmer Series 200 HPLC equipped with a UV detector and a 




mixture of water and methanol (30:70), delivered at a flow rate of 1 ml/min. Baicalin content was 
measured at 278 nm [14]. 
2.4. Rheological characterization 
Rheological measurements were carried out at 25±1 °C, using a Haake RheoStress 300 Rotational 
Rheometer, equipped with a Haake DC10 thermostat and data acquisition and elaboration software 
RheoWin. A cone-plate device (Haake CP35 TI diameter =35 mm) was used. Flow curves were 






: a stepwise increase of the stress was applied, with an 
equilibration time of 30 s. All the measurements were carried out in triplicate, at 25 °C [15,16]. 
2.5. In vitro skin delivery studies 
Non-occlusive experiments were performed using vertical Franz diffusion cells (0.785 cm
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diffusion area) and newborn pig skin. One day-old Goland-Pietrain hybrid pigs (~1.2 kg) were 
provided by a local slaughterhouse. The excised skin was pre-equilibrated in saline at 37°C for 12 
h, and then sandwiched between donor and receptor compartments of the Franz cells. The receptor 
was filled with saline (~6.5 ml), continuously stirred and thermostated at 37±1 °C. Samples (100 l 
containing baicalin 10 mg/ml) were applied onto the skin specimens (n=6). Every 2 h and up to 8 h, 
the receiving solution was withdrawn, refreshed, and analysed by HPLC for baicalin content. After 
8 h, the skin surface was gently washed with 1 ml of distilled water, and blotted on filter paper. The 
stratum corneum was removed by stripping with adhesive tape Tesa
®
 AG (Hamburg, Germany). 
Epidermis was separated from dermis with a surgical scalpel. The tape strips and the skin strata 
were cut, placed each in a flask with methanol, and sonicated for 2 min in an ice bath to extract 
baicalin. The tape and tissue suspensions were filtered out and assayed for baicalin content by 
HPLC (see paragraph 2.3). 
2.6. In vitro cell viability and protection against oxidative stress 
3T3 fibroblasts were grown as monolayer in 75 cm
2
 flasks incubated at 37 °C in humidified 




and supplemented with 10% foetal bovine serum, 1% penicillin/streptomycin and 1% fungizone, 
was used as growth medium. 
For the biocompatibility assay, the cells were seeded into 96-well plates at a density of 7.5 × 10
3
 
cells/well, and after 24 h of incubation they were exposed to different concentrations of baicalin in 
PBS or in the nanohydrogels (20, 10, 1, 0.1 μg/ml) for 24 and 48 h. The empty nanohydrogels were 
tested for the appropriate comparison. 
Cell viability was assessed by the MTT [3(4,5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium 
bromide] colorimetric assay, by adding 100 µl of MTT reagent (0.5 mg/ml in PBS) to each well. 
After 3 h, the formed formazan crystals were dissolved in dimethyl sulfoxide, and the concentration 
was spectrophotometrically determined at 570 nm with a microplate reader (Synergy 4, Reader 
BioTek Instruments, AHSI S.p.A, Bernareggio, Italy). The results are reported as the percentage of 
untreated cells (100% viability). 
For the antioxidant assay, the cells were seeded into 96-well plates at a density of 7.5×10
3
 
cells/well. After 24 h of incubation, cells were exposed to hydrogen peroxide (1:50000 dilution in 
PBS) for 4 h, in the presence of baicalin in PBS, or baicalin embedded in the nanohydrogel (final 
concentration of baicalin: 20, 10, 1, 0.1 μg/ml). Cells treated with hydrogen peroxide-only were 
used as a positive control. After 4 h of exposure, the cells were washed with fresh medium, and 
their viability was determined by the MTT assay, as above. 
2.7. In vivo topical application of baicalin nanohydrogels on TPA injured skin 
Female CD-1 mice (5-6 weeks old, 25-35 g) were obtained from Envigo RMS S.r.l. (San Pietro al 
Natisone, Italy). The experiments were performed in accordance with the European Union 
regulations for the handling and use of laboratory animals, and the protocols were approved by the 
Institutional animal care and use committee of the University of Valencia (code A1456917886577). 
The back skin of mice was shaved one day before the experiment. On day 1, cutaneous 




acetate, TPA; 20 l) dissolved in acetone (243 μM) on the shaved area (~2 cm2), and after 3 h, 
baicalin in PBS or in the nanohydrogels, or Betnovate
®
, a commercial betamethasone steroid cream, 
were topically smeared (20 μl each) over the same site. Untreated mice were used as a negative 
control, and mice treated with TPA and PBS were used as a positive control. The procedure was 
repeated on day 2 and 3. On day 4, mice were sacrificed by cervical dislocation, and the treated skin 
area was excised, weighed, and immediately stored at −80 °C. 
Oedema was measured as a function of the weight of the excised skin. The myeloperoxidase (MPO) 
activity was measured as previously reported [10]. Briefly, skin biopsies were homogenized and 
centrifuged. The supernatant was incubated with hydrogen peroxide and tetramethylbenzidine, and 
then assayed for MPO activity spectrophotometrically at 620 nm. The MPO activity was calculated 
from the linear portion of a standard curve. MPO and oedema inhibition were calculated as the 
percentage of values from treated animals vs. the positive control (TPA only-treated animals). 
In addition, the skin specimens were homogenized in 50 nM phosphate buffer pH 7.4 containing 
protease inhibitors. Tumour necrosis factor-α (TNF-α) was assayed by using a kit from R&D 
Systems (Minneapolis, MN, USA) with a sensitivity of 5.0 pg/ml. Data were expressed as the 
percentage of inhibition of the cytokine found in the skin treated with the formulations vs. the 
amount found in the skin injured by TPA (positive control). 
2.8. Statistical analysis of data 
Results are expressed as the mean  standard deviation. Analysis of variance (ANOVA test) was 
performed using IBM SPSS statistics for Windows. Post hoc testing (P<0.05) of the multiple 
comparisons was performed by the Scheffe’s or Dunnet’s test. 
3. RESULTS 
3.1. Nanohydrogel preparation and characterization 
Aiming at optimizing the formulation of the nanohydrogels for the delivery of baicalin, the 




chains in stable nanosized particles. Then, baicalin was added to the pre-formed nanohydrogels. The 
macroscopic appearance of the two nanohydrogels was very different: the sonicated one appeared 
as a yellow-transparent dispersion with some aggregated polymer particles adhering to the walls of 
the vial, while the autoclaved nanohydrogel appeared as a homogenous, yellow-transparent 
dispersion (Figure 1). 
The sonication process was not able to produce a nanohydrogel with small nanoparticles: the 
average size was > 500 nm, and the PI was > 0.4 (Table 1). On the contrary, as already described in 
the literature [17], the autoclave method was demonstrated to be more efficient, as the nanoparticles 
of the autoclaved nanohydrogel were smaller and more homogenously dispersed (~350 nm, PI 
≤0.30; Table 1), in accordance with the results of the visual observation. The zeta potential was 
sufficiently negative to ensure the stability of the nanohydrogels upon storage, thanks to the 
superficial electrostatic repulsion of the nanoparticles. The entrapment efficiency was 
approximately 37% for both nanohydrogels (Table 1). 
The flow curves of sonicated and autoclaved nanohydrogels were measured (Figure 2). In 
agreement with the size results, the sonicated nanohydrogel, which had shown larger particle 
diameter, displayed higher viscosity, indicating a reduction of the interparticle free water and the 
formation of particle-particle interactions. On the contrary, in the autoclaved nanohydrogel, which 
had shown smaller particle size, the amount of free water in the interparticle domains was higher, 
thus resulting in lower viscosity values. 
3.2. In vitro skin delivery of baicalin 
In vitro skin delivery studies were carried out on newborn pig skin, and the amount of baicalin 
accumulated in the different skin layers and recovered in the receptor fluid was expressed as a 
percentage of the amount of baicalin applied on the skin surface (Figure 3). Results showed a 
similar baicalin accumulation in the stratum corneum and dermis for all the tested formulations 




epidermis (~1%) significantly higher than that found using the polyphenol in PBS (~0.2%, p<0.05 
vs. nanohydrogels).  The amount of baicalin permeated into the receptor fluid was very low (~0.1%, 
p>0.05 among samples), irrespective of the formulation used. 
3.3. In vitro cell viability and protection against oxidative stress 
The biocompatibility of baicalin in PBS or embedded in nanohydrogels was assessed by using 3T3 
fibroblasts (Figure 4). The cells were incubated with the baicalin formulations using different 
sample dilutions (1:500, 1:1000, 1:10000, 1:100000 corresponding to 20, 10, 1, 0.1 g/ml of 
baicalin) for 24 and 48 h. After 24 and 48 h of exposure to baicalin in PBS, the viability of the cells 
was high (approximately 110%). A similar behaviour was observed after a 24h exposure to baicalin 
embedded in nanohydrogels, at all the dilution tested. After 48h, the viability of fibroblasts slightly 
decreased, but it was still around 100%, thus indicating a high biocompatibility of the 
nanohydrogels as well. 
In consideration of the well-known antioxidant properties of baicalin, the ability of the formulations 
to prevent the oxidative damage generated by hydrogen peroxide in 3T3 cell culture was evaluated 
(Figure 5). Hydrogen peroxide is a toxic oxidant for cells as it causes high mortality, corresponding 
to approximately 50% under the current experimental conditions. The simultaneous treatment of the 
cells with the oxidant and baicalin was able to counteract the oxidative effect of hydrogen peroxide, 
restoring normal conditions (~95% viability), regardless of the applied dose (20, 10, 1 and 0.1 
g/ml) and the formulation used (baicalin in PBS or embedded in nanohydrogels). These results 
confirmed the actual cytoprotective effect of this natural polyphenol, irrespective of its inclusion in 
the nanohydrogels. 
3.4. In vivo wound healing potential of baicalin 
The back skin of mice was injured by topically applied TPA, and the lesion was treated with the 




baicalin and their enhancement by incorporation into transfersomes have been previously 
demonstrated [10]: results reported therein showed that transfersomes loaded with baicalin at 
different concentrations (2.5, 5 and 10 mg/ml) healed TPA lesions and inhibited markers of 
inflammation (i.e. MPO) more efficiently than dexamethasone solution (a potent anti-inflammatory 
drug) and baicalin in PBS (10 mg/ml). 
In the present work, given the anti-inflammatory activity of baicalin, the efficacy of nanohydrogels 
was assessed and compared with that of Betnovate
®
, a commercial cream containing anti-
inflammatory betamethasone. Inflammation, which represents a part of the acute response to tissue 
injury, involves a coordinated influx of neutrophils that produce and release inflammatory 
mediators, and high levels of destructive proteases and oxygen free radicals. This can cause 
extensive tissue damage and prolong the inflammatory phase. Non-phagocytic cells also generate 
free radicals, leading to an accumulation of oxygen and nitrogen reactive species at the wound site. 
One of the major causes of delayed healing is the persistence of inflammation or an inadequate 
angiogenic response. It has been postulated that an anti-inflammatory response after cutaneous 
wounding is a prerequisite for healing. Potent antioxidant and anti-inflammatory agents can play an 
important role in restoring physiological conditions, allowing a significant improvement in wound 
healing. Their delivery at the wound site by innovative vesicles may improve their residence time, 
and favour their up-take by keratinocytes and fibroblasts. 
The macroscopic evaluation of the mice skin was performed at the end of the treatment by visual 
inspection (Figure 6). The skin treated with TPA only (positive control) appeared markedly 
damaged, with loss of epidermis, especially in the peripheral area, and a thin crust [18]. The wound 
formation was partially reduced by the betamethasone cream, as well as by baicalin in PBS, while it 
was strongly prevented by using the baicalin embedded in autoclaved nanohydrogel: the skin 




Additionally, the inhibition (expressed as inhibition percentage) of inflammation markers, such as 
oedema, MPO, and TNF-α was measured (Table 2). The treatment with betamethasone cream did 
not inhibit effectively the studied markers, as the obtained results were not statistically different 
from the positive control (p>0.05). The oedema and MPO inhibition provided by the baicalin 
autoclaved (A) nanohydrogel was the highest (78% and 44%, respectively; p<0.05 vs. positive 
control, betamethasone cream and baicalin in PBS), confirming the importance of the formulation 
in promoting baicalin efficacy on damaged skin. Additionally, the cytokine inhibition provided by 
baicalin autoclaved nanohydrogel was ~100% (p<0.05 vs. positive control, betamethasone cream 
and baicalin in PBS), which was the highest value obtained among the different formulations. 
Discussion 
Wounds are physical injuries characterized by an opening or breaking of the skin. This kind of 
injury is difficult to repair, and involves a set of pathological events. For the restoration of disrupted 
anatomical continuity and altered functional status of the skin, a proper treatment that delivers the 
drug to the deeper skin layers where pathological process occurs, is needed. Previous studies 
demonstrated that baicalin possesses stronger antioxidant activity than ascorbic acid and butylated 
hydroxytoluene [19]. Nanohydrogels have shown promising effects in the topical treatment of skin 
diseases, as a consequence of their ability to incorporate high volumes of water, thus acting as 
moisturizing agents and enhancing stratum corneum hydration [20]. Therefore, thanks to their 
favourable features (biocompatibility, hydration properties and nanosize), in the present work 
nanohydrogels were investigated as topical delivery systems capable of enhancing baicalin skin 
delivery and efficacy. The radical-scavenging capability of baicalin was assessed against the free 
radicals generated by hydrogen peroxide in cells, and the effect of the nanohydrogel carrier on the 
baicalin antioxidant activity was evaluated. 
The nanohydrogels were prepared by sonicating or autoclaving a gellan-cholesterol derivative: the 




homogeneously dispersed nanoparticles, which resulted in less viscous system due to a higher 
amount of free water in the interparticle domains [17]. Autoclaving and sonication, due to their 
different physico-chemical interactions with the polymer chains and the aqueous environment, led 
to the production of different nanohydrogel systems. In particular, we assume that they cause a 
different assembling of the polymer chains, which resulted in different particle features, especially 
in terms of size and homogeneity. 
The physico-chemical and technological properties of the prepared systems seem to indicate that the 
autoclaved (A) nanohydrogel is more suitable for baicalin delivery, because of its higher 
homogeneity (due to the particles’ features) and viscosity, as compared to baicalin in PBS, thus, 
ensuring a more effective spreadability of the formulation on the skin.  
Despite their different physico-chemical properties, the two nanohydrogels showed comparable 
performances in vitro, as they provided a similar accumulation of baicalin into the deeper skin 
layers. Both baicalin in PBS and embedded in the nanohydrogels were highly biocompatible and 
capable of protecting skin cells from oxidative stress caused by hydrogen peroxide by reducing cell 
mortality, thus confirming that the activity of the polyphenol in cells was not affected by the 
nanocarrier. 
Since the two nanohydrogel formulations showed similar performances in vitro, the in vivo studies 
were carried out using the autoclaved (A) nanohydrogel, by virtue of the abovereported best 
technological features (i.e., size, homogeneity, and viscosity). To evaluate the effect of the delivery 
system, the results were compared with those of baicalin in PBS and a commercial cream 
containing betamethasone, a potent steroidal anti-inflammatory drug. The topical administration of 
the baicalin autoclaved nanohydrogel onto TPA-injured mouse skin led to complete wound healing, 
as indicated by visual observation. In addition, from a quantitative point of view, this formulation 
led to a complete inhibition of TNF- and almost complete inhibition of oedema. The 




nature, the nanohydrogel acts as moisturizing agent on the stratum corneum, leading to the 
accumulation of baicalin in the epidermis, followed by its diffusion into the dermis where it can 
counteract oxidative stress, regulating the inflammation process and promoting skin repair. 
Conclusions 
Gellan-cholesterol nanohydrogels were produced by using two different methods: sonication and 
autoclaving. The autoclaved nanohydrogel seems to be the most promising carrier in terms of size, 
homogeneity, and rheological properties. The suitability of both nanohydrogels as carriers for 
baicalin skin delivery was evaluated, and the superior performances in comparison with baicalin in 
PBS were demonstrated. Further, the autoclaved nanohydrogel showed optimal performances in the 
topical treatment of skin wound, and might be proposed as an effective formulation against skin 
diseases related to inflammation and oxidative stress. 
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Figure 1. Macroscopic appearance of baicalin sonicated (S) and autoclaved (A) nanohydrogels. 
Figure 2. Representative flow curves of baicalin sonicated (S) and autoclaved (A) nanohydrogels. 
Figure 3. Baicalin accumulated in the stratum corneum (SC), epidermis (EP) dermis (D) and 
receptor fluid (RF) after application of baicalin in PBS or in sonicated (S) or autoclaved (A) 
nanohydrogels after 8 h. Mean values ± standard deviation (error bars) are reported. 
Figure 4. In vitro viability of 3T3 fibroblasts incubated for 24 h (A) and 48 h (B) with different 
sample dilutions corresponding to 20, 10, 1 and 0.1 g/ml of baicalin in PBS or in sonicated (S) or 
autoclaved (A) nanohydrogels. Data are reported as mean values ± standard deviation of cell 
viability expressed as the percentage of untreated cells (100% viability).
Figure 5. In vitro viability of 3T3 fibroblasts treated for 4 h with hydrogen peroxide and different 
sample dilutions corresponding to 20, 10, 1 and 0.1 g/ml of baicalin in PBS or in sonicated (S) or 
autoclaved (A) nanohydrogels. Data are reported as the mean values ± standard deviation of cell 
viability expressed as the percentage of untreated cells (100% viability). 
Figure 6. Back skin of mice treated with PBS only (negative control) or exposed to TPA and 
treated with PBS (positive control), or betamethasone commercial cream (Betnovate
®
), baicalin in 






















Table 1. Mean diameter (MD), polydispersity index (PI), zeta potential (ZP) and entrapment 
efficiency (EE) of empty and baicalin sonicated (S) or autoclaved (A) nanohydrogels. Each value 










Empty S nanohydrogel 554±61 0.45 -30±7  
Empty A nanohydrogel 383±23 0.19 -24±2  
Baicalin S nanohydrogel 507±68 0.49 -25±3 38±9 




Table 2. Inhibition of oedema, MPO and TNF-α in mice exposed to TPA and treated with PBS (positive 
control), or betamethasone commercial cream, baicalin in PBS or in autoclaved (A) nanohydrogel. Mean 














Positive control 0 0 0 
Betamethasone cream 43±28 0 0 
Baicalin in PBS 25±20 23±18 4±3 
Baicalin A nanohydrogel *78±15 °44±25 
+
100±26 
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